Adagene Management to Present in Boston on November 9
The firm will hold a fireside chat at the 3rd Annual Guggenheim Securities Healthcare Innovation Conference in November.
Updated on Oct. 27, 2026 in Biotech
Adagene senior management is scheduled to participate in a fireside chat and one-on-one meetings at the 3rd Annual Guggenheim Securities Healthcare Innovation Conference in Boston. The event will take place on November 9, 2026.
Why it matters
Investor conferences serve as key venues for biotechnology leadership to outline operational strategy and development timelines to market stakeholders. This session provides a public venue to discuss the company's research and corporate trajectory.
The firm has scheduled a 25-minute fireside chat from 9:00 a.m. to 9:25 a.m. ET. A webcast of the session will be accessible on the company website for a minimum of 30 days.
The players
Adagene
A biotechnology firm developing antibody-based therapies with operations in San Diego and Suzhou.
Guggenheim Securities
An investment banking firm that facilitates capital markets and annual healthcare innovation forums.
The details
Management will engage in discussions regarding the company's current biotechnology pipeline and strategic direction. The firm operates with research and development headquarters in both San Diego and Suzhou, China, focusing on antibody-based therapeutics. Participation is limited to scheduled one-on-one sessions arranged through institutional representatives.
Timeline
November 9, 2026, 9:00 a.m. to 9:25 a.m. ET: Fireside chat.
November 9-11, 2026: Guggenheim Securities Healthcare Innovation Conference duration.
The Tech Race
This conference participation places the firm within the broader 2026 healthcare innovation cycle. It represents a recurring milestone for biotech companies to maintain investor visibility amid competitive clinical development timelines.
Institutional investors and industry analysts can request one-on-one meetings by contacting a Guggenheim representative. A public webcast will remain available online for one month following the conference date.
The takeaway
This session offers a window into the strategic research priorities of the firm as it moves through its 2026 development cycle. Interested parties should monitor the corporate investor site for the post-event webcast release.
Further reading
For more on industry developments in the city, visit Biotech.
More information
View official scheduling updates on the Company investor relations website.
